ClinicalTrials.gg
Drug

Linagliptin clinical trials

Also written BI 1356 and Trajenta.

studies test it
129
open now
3
in phase 3
36
first study started
2004
Related medicines add 2 studies

Counted the way a researcher would: Linagliptin with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Linagliptin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Linagliptin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
2 May 2011 · TRADJENTA · NDA 201280 (FDA, Drugs@FDA)
European Union
23 Aug 2011 · Trajenta · EMEA/H/C/002110 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Linagliptin
68
Tradjenta
10
Linagliptin 5mg
3
BI 1356 BS - Tablet
2
BI 1356, high dose
2

Brand

Trajenta
12
Trajenta 5 mg
1
Trajenta 5mg
1

Development codes

BI 1356
15

In one entry with another drug

Given together, or one or the other

Linagliptin/Metformin FDC
4
Linagliptin + metformin
3
Empagliflozin/Linagliptin/Metformin HCl Extended Release Tablet
2
Empagliflozin/Linagliptin/Metformin HCL
2
Linagliptin and Metformin
2
Linagliptin/Metformin ER FDC
2

Studies by the year they started

129 studies that test it; most in 2008 (19)

Studies that test Linagliptin, by start year
YearStudies
20041
20055
20065
20072
200819
20096
201013
20113
20128
201313
201412
20155
20167
20179
20183
20192
20203
20212
20222
20231
20242
20253
20263

By phase

A phase 1/2 study counts in both.

Phase 1
53
Phase 2
7
Phase 3
36
Phase 4
31
No phase
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 88 · Other 41

Boehringer Ingelheim (73) · Humanis Saglık Anonim Sirketi (4) · Universidad de Guanajuato (4) · Dong Wha Pharmaceutical Co. Ltd. (3) · Emory University (2) · Profil Institut für Stoffwechselforschung GmbH (2) · Hoffmann-La Roche (2) · Rabin Medical Center (2)

Often tested with

Tested in the same studies.

Metformin (23) · Empagliflozin (20) · Dapagliflozin (2) · Pioglitazone (2) · Sitagliptin (2) · Insulin Glargine (2) · Gliclazide (2) · Cobimetinib (2)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses Linagliptin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 129

See all 129 studies that test Linagliptin →

Given beside what is tested · 7 — Linagliptin is usual care or a partner of the new treatment
As the comparator · 16 — what is tested is compared with Linagliptin

Codes

What other systems call Linagliptin · ClinicalTrials.gg INT006598

  • MeSH (NLM) D000069476LinagliptinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 3X29ZEJ4R2LINAGLIPTINConfirmed FDA, NLM, Wikidata
  • RxNorm 1100699Confirmed FDA, Wikidata
  • Wikidata Q909745linagliptinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C83887LinagliptinOne source FDA
  • DrugBank DB08882One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.